Table 1.
Baseline characteristics. Results are no.(%) or mean (SD) unless otherwise specified.
| Patients (completed study) | 29 |
|---|---|
| Men (n (%)) | 16 (55) |
| Age (years) | 39.4 (12.5) |
| BMI (kg/m2) | 24.9 (2.5) |
| Years with asthma (years) | 17 (14) |
| Use ICS (n (%)) | 22 (76) |
| ICS dose (Budesonide equivalents at entry, ug) |
645 (440) |
| Smoking (n (%)) | |
| No | 21 (72) |
| Yes | 0 (0) |
| Former | 8 (29) |
| ACQ | 1.7 (0.6) |
| ACQ < 1.5 (n (%)) | 18 (62) |
| FEV1%pred | 84 (13) |
| FVC %pred | 93 (10) |
| FEV1/FVC | 0.91 (0.08) |
| Positive AHR (n (%)) (n = 28) |
21 (75) |
| FeNO (ppb) a | 28.5 (23.8) |
| Atopy (n (%)) | 21 (72) |
ACQ = Asthma Control Questionnaire Score
ICS = Inhaled corticosteroids
FEV1%pred. = Forced expiratory volume in 1 s in percent of predicted
FVC %pred. = Forced vital capacity in percent of predicted
AHR = airway hyperresponsiveness
FeNO = Fraction of exhaled nitric oxide (parts per billion).
a Median (interquartile range).